Skip to main content

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Projects

Aproximación clínico-genética a la etiopatogénica del trastorno del espectro autista (TEA) y del trastorno por déficit de atención con hiperactividad (TDHA): Estudio en una muestra de niños y adultos con TDAH

IP: Miquel Casas Brugué
Collaborators: Xavier Agustin Gastaminza Pérez, Alfons Macaya Ruíz, José Antonio Ramos Quiroga
Funding agency: Instituto de Salud Carlos III
Funding: 66700
Reference: PI040524
Duration: 01/01/2005 - 28/11/2007

Avaluació de gens de susceptibilitat a la migranya mitjançant estudis d'associació a variants polimòrfiques tipus SNP

IP: Alfons Macaya Ruíz
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13200
Reference: PRED/IR-HUVH/30/2004
Duration: 01/01/2005 - 31/12/2008

Biología, clínica y terapia de la ataxias cerebelosas.

IP: Alfons Macaya Ruíz
Collaborators: Josep Gamez Carbonell
Funding agency: Instituto de Salud Carlos III
Funding: 90000
Reference: G03/056
Duration: 01/01/2003 - 31/12/2005

Evaluación de genes de susceptibilidad a migraña mediante estudios de asociación a variantes polimórficas tipo SNP y análisis de ligamento genético en sujetos y familias con migraña.

IP: Alfons Macaya Ruíz
Collaborators: Mireia Del Toro Riera
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 92000
Reference: SAF2003-04704
Duration: 15/12/2003 - 14/12/2006

Ministerio de Ciencia

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

Related professionals

Inmaculada Jimenez Ariza

Inmaculada Jimenez Ariza

Gestió i Administració
Accounting and Revenue Unit
Finance Directorate
Read more
Gemma Parramon Puig

Gemma Parramon Puig

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Xavier Nuvials Casals

Xavier Nuvials Casals

Senior researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Lorena Valero Arrese

Lorena Valero Arrese

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.